WAY insider plans sale of 60,038 shares
Matthew J. Hawkins filed to sell common stock of WAY under Rule 144.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Matthew J. Hawkins filed to sell common stock of WAY under Rule 144. The notice lists a planned sale of 60,038 shares through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $1,473,332.52, following recent option exercises.
Over the prior three months, Hawkins reported multiple sales of WAY common stock, including 22,462 shares for $562,354.14 on August 11, 2026 and 36,901 shares for $851,944.46 on July 16, 2026, some executed under a 10b5-1 trading plan.
Key Figures
Key Terms
Rule 144 regulatory
10b5-1 regulatory
Exercise of Stock Options financial
aggregate market value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing for WAY by Matthew J. Hawkins disclose?
What recent WAY stock sales by Matthew J. Hawkins are listed in the Form 144?
Are the WAY stock sales by Matthew J. Hawkins under a 10b5-1 trading plan?
What is the role of Morgan Stanley Smith Barney LLC in the WAY Form 144 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.